GlassScriptPhysician profile
Christopher J Lenarz
NPI 1982808739
$13,587.66
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,871 · 2020: $1,134 · 2021: $639 · 2022: $1,319 · 2023: $1,313 · 2024: $4,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,945 · Travel and Lodging: $2,177 · Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,945.00 |
| Travel and Lodging | $2,177.01 |
| Food and Beverage | $503.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $8,680.64 | 2019-2024 | |
| International Rehabilitative Sciences, INC | $2,945.00 | 2024 | Rs 4i Plus Sequential Stimulator |
| Stryker Corporation | $815.65 | 2019-2024 | Blueprint Patient Specific Instrumentation |
| Linvatec Corporation | $680.69 | 2023 | Biobrace 23mm, Livatec Knee Preservation System, Linvatec Shoulder Arthroscopy |
| Catalyst Orthoscience | $145.47 | 2024 | R1 Reverse Shoulder System, Catalyst Csr Shoulder System |
| Exactech, INC. | $118.71 | 2022 | |
| Wright Medical Technology, INC. | $108.88 | 2019 | |
| Depuy Synthes Sales INC. | $62.90 | 2024 | Healix Knotless Peek, Dynatape, Gryphon Orthocord |
| Arthrex, INC. | $16.00 | 2021 | |
| Smith+Nephew, INC. | $13.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lenarz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.